GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (FRA:3G6) » Definitions » Cyclically Adjusted PS Ratio

GNI Group (FRA:3G6) Cyclically Adjusted PS Ratio : 10.17 (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is GNI Group Cyclically Adjusted PS Ratio?

As of today (2024-05-26), GNI Group's current share price is €12.00. GNI Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €1.18. GNI Group's Cyclically Adjusted PS Ratio for today is 10.17.

The historical rank and industry rank for GNI Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:3G6' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.08   Med: 25.42   Max: 81.59
Current: 10.28

During the past years, GNI Group's highest Cyclically Adjusted PS Ratio was 81.59. The lowest was 7.08. And the median was 25.42.

FRA:3G6's Cyclically Adjusted PS Ratio is ranked worse than
72.13% of 506 companies
in the Biotechnology industry
Industry Median: 5.565 vs FRA:3G6: 10.28

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

GNI Group's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.703. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €1.18 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


GNI Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for GNI Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group Cyclically Adjusted PS Ratio Chart

GNI Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.15 26.74 15.71 10.37 14.81

GNI Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.24 8.48 11.34 14.81 15.22

Competitive Comparison of GNI Group's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, GNI Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GNI Group's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where GNI Group's Cyclically Adjusted PS Ratio falls into.



GNI Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

GNI Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=12.00/1.18
=10.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GNI Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, GNI Group's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.703/107.2000*107.2000
=0.703

Current CPI (Mar. 2024) = 107.2000.

GNI Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.020 98.000 0.022
201409 0.027 98.500 0.029
201412 0.040 97.900 0.044
201503 0.052 97.900 0.057
201506 0.053 98.400 0.058
201509 0.052 98.500 0.057
201512 0.061 98.100 0.067
201603 0.072 97.900 0.079
201606 0.058 98.100 0.063
201609 0.073 98.000 0.080
201612 0.114 98.400 0.124
201703 0.085 98.100 0.093
201706 0.082 98.500 0.089
201709 0.142 98.800 0.154
201712 0.219 99.400 0.236
201803 0.191 99.200 0.206
201806 0.217 99.200 0.235
201809 0.275 99.900 0.295
201812 0.264 99.700 0.284
201903 0.299 99.700 0.321
201906 0.361 99.800 0.388
201909 0.368 100.100 0.394
201912 0.386 100.500 0.412
202003 0.400 100.300 0.428
202006 0.418 99.900 0.449
202009 0.459 99.900 0.493
202012 0.495 99.300 0.534
202103 0.631 99.900 0.677
202106 0.407 99.500 0.438
202109 0.491 100.100 0.526
202112 0.504 100.100 0.540
202203 0.631 101.100 0.669
202206 0.626 101.800 0.659
202209 0.673 103.100 0.700
202212 0.679 104.100 0.699
202303 0.617 104.400 0.634
202306 1.356 105.200 1.382
202309 0.836 106.200 0.844
202312 0.674 106.800 0.677
202403 0.703 107.200 0.703

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GNI Group  (FRA:3G6) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


GNI Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of GNI Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GNI Group (FRA:3G6) Business Description

Industry
Traded in Other Exchanges
Address
Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group (FRA:3G6) Headlines

No Headlines